Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to $3.9 million.

  • Utah Medical Products' Free Cash Flow rose 222.99% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.9 million, marking a year-over-year decrease of 1793.67%. This contributed to the annual value of $14.6 million for FY2024, which is 3253.4% down from last year.
  • Utah Medical Products' Free Cash Flow amounted to $3.9 million in Q3 2025, which was up 222.99% from $2.8 million recorded in Q2 2025.
  • In the past 5 years, Utah Medical Products' Free Cash Flow ranged from a high of $6.9 million in Q1 2023 and a low of $2.7 million during Q2 2024
  • In the last 5 years, Utah Medical Products' Free Cash Flow had a median value of $4.7 million in 2021 and averaged $4.6 million.
  • As far as peak fluctuations go, Utah Medical Products' Free Cash Flow soared by 4289.87% in 2023, and later tumbled by 4414.35% in 2024.
  • Utah Medical Products' Free Cash Flow (Quarter) stood at $4.7 million in 2021, then increased by 19.18% to $5.6 million in 2022, then decreased by 7.09% to $5.2 million in 2023, then plummeted by 44.14% to $2.9 million in 2024, then soared by 31.52% to $3.9 million in 2025.
  • Its Free Cash Flow stands at $3.9 million for Q3 2025, versus $2.8 million for Q2 2025 and $4.3 million for Q1 2025.